CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis
CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis have?
CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis has 1 citations in the OpenAlex counts ScholarIQ stores.
When was CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis published?
CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis has 2017 year in the ScholarIQ index.
What is the open-access status of CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis?
CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis has closed oa status in the ScholarIQ index.
What is the DOI of CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis?
The DOI for CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis is on the source record.
What is the OpenAlex record for CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis?
The OpenAlex for CP-221 Clinical experience with intrathecal rituximab for treatment of progressive multiple sclerosis is on the source record.